HbA1c Testing Market Size

ID: MRFR/HC/7045-CR

134 Pages

Kinjoll Dey

October 2019

HbA1c Testing  Market Research Report Information by Product (Instruments (Bench-Top Device and Handheld Device) and Reagents and Kits), By Technology (Ion-Exchange High-Performance Liquid Chromatography (HPLC), Turbidimetric Inhibition Immunoassay (TINIA), Enzymatic Assay and Others), By End User (Hospitals and Clinics, Diagnostic Laboratories and Others) and by Region (Americas, Europe, ...

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Download PDF

Hba1c Testing Size

HbA1c Testing Market Growth Projections and Opportunities

Hemoglobin A1c (HbA1c) is a variant of hemoglobin that becomes bound to glucose in the bloodstream. This specific type of hemoglobin serves as the focus of the HbA1c test, offering patients insights into their average blood sugar levels over a span of 2 to 3 months. The test is alternatively referred to as the glycated hemoglobin test or glycohemoglobin test. Understanding HbA1c levels is crucial in managing diabetes. The normal range for HbA1c is considered to be less than 6%. This percentage represents the proportion of hemoglobin that has bonded with glucose during the testing period. In essence, a lower HbA1c value indicates better blood sugar control within the specified timeframe. When HbA1c levels surpass the normal range and rise above 6%, it signals potential challenges in diabetes management. Elevated HbA1c levels are indicative of inadequate control over blood sugar levels. This means that over the past 2 to 3 months, blood sugar levels have been consistently higher than what is considered optimal for diabetes management. Monitoring HbA1c levels is thus a critical aspect of diabetes care, providing a more comprehensive and extended perspective on glycemic control compared to regular blood sugar tests. The HbA1c test is particularly beneficial because it reflects the average blood sugar concentration over a more extended period, offering a more stable and reliable indicator of diabetes management. This is in contrast to daily blood sugar tests, which provide momentary snapshots and may not capture the overall trend. As a result, healthcare professionals commonly use the HbA1c test to assess the effectiveness of diabetes treatment plans and to make informed adjustments as needed. In summary, HbA1c is a significant marker in diabetes management, offering a retrospective view of blood sugar control over the past 2 to 3 months. Maintaining HbA1c levels within the normal range is essential for effective diabetes care, as it reflects optimal blood sugar control and reduces the risk of complications associated with poorly managed diabetes. Regular monitoring through the HbA1c test enables individuals and healthcare providers to make informed decisions to enhance diabetes management and overall well-being.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future Analysis, the HbA1c Testing Market was valued at USD 1.68 Billion in 2023 and is projected to reach USD 4.56 Billion by 2032, growing at a CAGR of 13.12% from 2024 to 2032. The market is driven by the rising prevalence of diabetes, advancements in testing technologies, and increasing healthcare infrastructure. The COVID-19 pandemic initially hindered testing volumes but has since led to a resurgence in demand. Key players in the market include Bio-Rad Laboratories, Abbott Laboratories, and Siemens Healthineers, among others.

Key Market Trends & Highlights

The HbA1c Testing Market is witnessing significant growth due to various factors.

Market Size in 2023: USD 1.68 Billion. Projected Market Size by 2032: USD 4.56 Billion. CAGR from 2024 to 2032: 13.12%. Dominant Technology: Ion-exchange HPLC holds the largest market share.

HbA1c Testing Market

CAGR

13.12%.

Market Size & Forecast

2023 Market Size	USD 1.68 Billion
2024 Market Size	USD 1.80 Billion
2032 Market Size	USD 4.56 Billion
CAGR (2024-2032)	13.12%.

Major Players

Bio-Rad Laboratories, Inc.; Abbott Laboratories; ARKRAY, Inc.; Danaher Corporation; Hoffmann-La Roche Ltd; Siemens Healthineers.

Market Trends

The increasing prevalence of diabetes globally underscores the critical need for reliable HbA1c testing, which is essential for effective disease management and prevention strategies.

Centers for Disease Control and Prevention (CDC)

HbA1c Testing Market Market Drivers

Growing Aging Population

The global aging population is a crucial driver of the Global HbA1c Testing Market Industry. As individuals age, the risk of developing diabetes increases, necessitating regular monitoring of blood glucose levels. By 2035, it is estimated that the number of older adults with diabetes will reach 300 million, further emphasizing the need for effective testing solutions. This demographic shift is likely to result in a heightened demand for HbA1c testing, as healthcare providers seek to manage the health of older patients more effectively. Consequently, the market is expected to expand significantly, reflecting the growing healthcare needs of an aging population.

Market Growth Projections

The Global HbA1c Testing Market Industry is projected to experience substantial growth, with estimates indicating a market value of 1.8 USD Billion in 2024 and a remarkable increase to 6.6 USD Billion by 2035. This growth trajectory suggests a robust demand for HbA1c testing solutions, driven by various factors including technological advancements, rising diabetes prevalence, and increased awareness of diabetes management. The compound annual growth rate of 12.54% from 2025 to 2035 further underscores the market's potential for expansion. These projections highlight the critical role that HbA1c testing will play in the ongoing efforts to manage diabetes effectively on a global scale.

Rising Prevalence of Diabetes

The increasing prevalence of diabetes globally drives the Global HbA1c Testing Market Industry. As of 2024, approximately 537 million adults are living with diabetes, a figure projected to rise significantly in the coming years. This surge necessitates regular monitoring of blood glucose levels, with HbA1c testing being a critical tool for managing diabetes. The demand for accurate and reliable testing methods is likely to grow, as healthcare providers emphasize the importance of maintaining optimal glycemic control to prevent complications. Consequently, the market is expected to expand, reflecting the urgent need for effective diabetes management solutions.

Government Initiatives and Funding

Government initiatives aimed at combating diabetes and promoting preventive healthcare are significantly influencing the Global HbA1c Testing Market Industry. Various countries are implementing programs to increase awareness about diabetes management and the importance of regular HbA1c testing. For example, public health campaigns and funding for diabetes education programs are being rolled out to encourage early diagnosis and treatment. These initiatives not only enhance public awareness but also facilitate access to testing services, thereby driving market growth. As governments continue to prioritize diabetes care, the market is likely to benefit from increased funding and resources dedicated to HbA1c testing.

Technological Advancements in Testing

Technological innovations in HbA1c testing methodologies are propelling the Global HbA1c Testing Market Industry forward. Newer devices and testing kits offer enhanced accuracy, faster results, and user-friendly interfaces, making them more appealing to both healthcare professionals and patients. For instance, point-of-care testing devices are gaining traction, allowing for immediate results in clinical settings. This shift towards more efficient testing solutions is likely to increase adoption rates, thereby contributing to market growth. As technology continues to evolve, the market is expected to witness a compound annual growth rate of 12.54% from 2025 to 2035, reflecting the ongoing demand for advanced testing options.

Increased Awareness of Diabetes Management

There is a growing awareness of the importance of diabetes management among patients and healthcare providers, which is positively impacting the Global HbA1c Testing Market Industry. Educational initiatives and resources are being developed to inform individuals about the significance of maintaining optimal HbA1c levels. This heightened awareness encourages patients to seek regular testing and adhere to treatment plans, ultimately leading to better health outcomes. As more individuals recognize the value of proactive diabetes management, the demand for HbA1c testing is likely to rise, contributing to the overall growth of the market.

Market Segment Insights

HbA1c Testing Technology Insights

Based on the technology, the global hemoglobin testing market is classified into few types as ion-exchange HPLC, <a href="https://www.marketresearchfuture.com/reports/tinea-corporis-market-6838">TINIA</a>, enzymatic assay, and others. Out of these, ion-exchange HPLC is holding the largest market share for its high demand in the market. It is the most widely used testing kit that consumes less time, recognizes variants, and is also used in point-of-care settings. TINIA is expected to grow at a significant rate during the review period which offers the benefits like accurate results, cost-effectiveness, and quick-swiftness.

HbA1c Testing Product Insights

The global HbA1c testing machine market based on the product is bifurcated into two types as reagents & kits, and instruments. Further, the instruments are divided into a bench-top device and a handheld device.

HbA1c Testing End-user Insights

By end-user, the global HbA1c testing equipment market is analyzed into hospitals &clinics, diagnostic laboratories, and others. The hospitals &clinics segment is dominating the HbA1c testing market share due to the growing geriatric population worldwide.

HbA1c Testing Region Insights

Regionally, the global Hemoglobin testing machine market is categorized into four main geographies such as Europe, Asia-Pacific, America, and the Middle East & Africa. America is dominating the largest market share for its rising activities like awareness campaigns, research, and joint ventures by public and private organizations in emerging countries like the US and Canada.

HbA1c Testing Market Regional Analysis

Geographically, the HbA1c testing global market is divided into four major regions like Asia-Pacific, Europe, America, and the Middle East & Africa. Out of these regions, America is holding the leading position in the market of HbA1c testing for its rising activities like awareness campaigns, research, and joint ventures by public and private organizations in the US and Canada. Europe is predicted to hold the second-largest market share for their increasing adoption of advanced diagnostic tools and devices coupled with strategic activities like partnerships and agreements by the major key players is accelerating the market growth in this region.

Get more detailed insights about HbA1c Testing Market Research Report - Forecast till 2032

Regional Insights

Key Companies in the HbA1c Testing Market market include

Industry Developments

February 2023:Bio-Rad Laboratories, Inc. (US) launched the D-100 Hemoglobin A1c assay, a high-performance liquid chromatography (HPLC) method offering accurate and precise HbA1c measurement on their D-Series analyzers.

August 2022:Transasia Bio-Medicals (India) received approval from the Indian Council of Medical Research (ICMR) for their HbA1c self-testing kit, marking a significant step towards increased accessibility in India.

October 2023:Abbott Laboratories (US) received FDA clearance for the FreeStyle Libre 3 system, a continuous glucose monitoring (CGM) device offering 14-day wear and improved accuracy. While not directly an HbA1c test, CGM data can be used to estimate HbA1c levels.

Future Outlook

HbA1c Testing Market Future Outlook

The HbA1c Testing Market is projected to grow at a 12.54% CAGR from 2024 to 2032, driven by technological advancements, increasing diabetes prevalence, and rising awareness of chronic disease management.

New opportunities lie in:

Develop portable HbA1c testing devices for home use to enhance patient convenience. Invest in AI-driven analytics for personalized diabetes management solutions. Expand partnerships with healthcare providers to integrate HbA1c testing into routine check-ups.

By 2035, the HbA1c Testing Market is expected to reach substantial growth, reflecting enhanced healthcare strategies and technological integration.

Market Segmentation

HbA1c Testing Region Outlook

{"Asia-Pacific"=>["China"
"Japan"
"India"
"Australia"
"South Korea"
"Rest of Asia-Pacific"]}
{"Rest of the World"=>["Middle East"
"Africa"
"Latin America"]}

HbA1c Testing Product Outlook

Reagents & kits
Instruments

HbA1c Testing End-user Outlook

Hospitals & clinics
Diagnostic laboratories
others

HbA1c Testing Technology Outlook

Ion-exchange HPLC
TINIA
enzymatic assay
others

Report Scope

Report Attribute/Metric	Details
Market Size 2023	1.68 (USD Billion)
Market Size 2024	1.80 (USD Billion)
Market Size 2032	4.56 (USD Billion)
Compound Annual Growth Rate (CAGR)	13.12 % (2024 - 2032)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2023
Market Forecast Period	2024 - 2032
Historical Data	2018-2022
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), ARKRAY, Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), Siemens Healthineers (US), Transasia Bio-Medicals (India), EKF Diagnostics (UK), Agappe Diagnostics Ltd (India), PTS Diagnostics (US), DiaSys Diagnostic Systems GmbH (Germany), CPC Diagnostics Pvt. Ltd. (India), Trinity Biotech PLC (Ireland), Rapid Diagnostics Group of Companies (India), and Tosoh India Pvt. Ltd. (India)
Key Market Opportunities	Growing adoption of advanced diagnostic tools and devices coupled with the strategic activities such as partnerships and agreements by the prominent players
Key Market Drivers	Developing healthcare infrastructure and increasing per capita disposable incomes Availability of new advanced treatment options

Market Highlights

Author

Kinjoll Dey

Research Analyst Level I

She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Latest Comments

John Doe

john@example.com

This is a great article! Really helped me understand the topic better.

Posted on July 23, 2025, 10:15 AM

Jane Smith

jane@domain.com

Thanks for sharing this. I’ve bookmarked it for later reference.

Posted on July 22, 2025, 7:45 PM

View All

FAQs

At what CAGR is the HbA1c Testing Market projected to grow during the forecast period?

HbA1c Testing Market is projected to grow at a 13.12% CAGR between 2024-2032.

Which region is expected to dominate the HbA1c Testing Market?

The Americas is expected to dominate the HbA1c Testing Market.

What will be the value of the HbA1c Testing Market during the forecast period?

HbA1c Testing Market is predicted to touch USD 4.56 Billion by 2032.

Which end user segment will lead the HbA1c Testing Market?

The hospitals and clinics segment will lead the HbA1c Testing Market.

Which product segment will dominate the HbA1c Testing Market?

The reagents & kits segment will dominate the HbA1c Testing Market.

--- '1 Executive Summary
1. MARKET SYNOPSIS 14
2. MARKET ATTRACTIVENESS ANALYSIS 15
3. GLOBAL HBA1C TESTING MARKET, BY PRODUCT 16
4. GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY 17
5. GLOBAL HBA1C TESTING MARKET, BY END USER 18
Market Introduction
1. DEFINITION 19
2. Scope of the Study 19
3. RESEARCH OBJECTIVE 19
4. MARKET STRUCTURE 20
5. ASSUMPTIONS & LIMITATIONS 20
Research Methodology
1. DATA MINING 21
2. SECONDARY RESEARCH 22
3. PRIMARY RESEARCH 23
4. BREAKDOWN OF PRIMARY RESPONDENTS 24
5. FORECASTING TECHNIQUES 25
6. Research Methodology FOR MARKET SIZE ESTIMATION 26
  1. Bottom-up Approach 27
  2. TOP-DOWN APPROACH 27
7. DATA TRIANGULATION 28
8. VALIDATION 28
MARKET DYNAMICS
1. OVERVIEW 29
2. DRIVERS 30
  1. RISING PREVALENCE OF DIABETES 30
  2. INCREASING INITIATIVES BY KEY PLAYERS 30
  3. GROWING NUMBER OF RESEARCH ORGANIZATIONS AND ASSOCIATIONS FOR DIABETES 30
  4. INCREASING GERIATRIC POPULATION AND THE INFLUENCE OF SEDENTARY LIFESTYLE AND UNHEALTHY DIET 30
3. RESTRAINTS 32
  1. LIMITED INDICATIONS OF HBA1C TESTS 32
  2. STRINGENT REIMBURSEMENT POLICIES IN DEVELOPING COUNTRIES 32
4. OPPORTUNITIES 33
  1. INCREASING APPROVALS AND PRODUCT LAUNCHES 33
  2. INCORPORATION OF VARIOUS TECHNOLOGIES IN HBA1C TESTING INSTRUMENTS 33
MARKET FACTOR ANALYSIS
1. PORTER’S FIVE FORCES MODEL 34
  1. THREAT OF NEW ENTRANTS 34
  2. BARGAINING POWER OF SUPPLIERS 35
  3. THREAT OF SUBSTITUTES 35
  4. BARGAINING POWER OF BUYERS 35
  5. INTENSITY OF RIVALRY 35
2. VALUE CHAIN ANALYSIS 36
  1. R&D AND DESIGNING 37
  2. MANUFACTURING 37
  3. DISTRIBUTION 37
  4. MARKETING & SALES 37
  5. POST-SALES MONITORING 37
HBA1C TESTING MARKET, BY PRODUCT
1. OVERVIEW 38
2. REAGENTS & KITS 39
3. INSTRUMENTS 40
  1. BENCH-TOP DEVICE 41
  2. HANDHELD DEVICE 42
HBA1C TESTING MARKET, BY TECHNOLOGY
1. OVERVIEW 43
2. ION-EXCHANGE HPLC 44
3. ENZYMATIC ASSAY 45
4. TURBIDIMETRIC INHIBITION IMMUNOASSAY (TINIA) 46
5. OTHERS 46
HBA1C TESTING MARKET, BY END USER
1. OVERVIEW 47
2. HOSPITALS AND CLINICS 48
3. DIAGNOSTIC LABORATORIES 49
4. OTHERS 49
GLOBAL HBA1C TESTING MARKET, BY REGION
1. OVERVIEW 50
2. AMERICAS 52
HBA1C TESTING MARKET, BY PRODUCT
HBA1C TESTING MARKET, BY TECHNOLOGY
HBA1C TESTING MARKET, BY END USER
1. OVERVIEW 52
  1. NORTH AMERICA 55
  2. LATIN AMERICA 62
2. EUROPE 64
  1. OVERVIEW 64
  2. WESTERN EUROPE 67
  3. EASTERN EUROPE 82
3. ASIA-PACIFIC 84
  1. OVERVIEW 84
  2. CHINA 87
  3. INDIA 89
  4. JAPAN 91
  5. SOUTH KOREA 93
  6. AUSTRALIA 95
  7. REST OF ASIA-PACIFIC 97
4. MIDDLE EAST & AFRICA 99
  1. OVERVIEW 99
  2. MIDDLE EAST 102
  3. AFRICA 104
Competitive Landscape
1. OVERVIEW 106
2. COMPANY SHARE ANALYSIS, 2020 (%) 106
COMPANY PROFILES
1. ABBOTT LABORATORIES 108
  1. COMPANY OVERVIEW 108
  2. FINANCIAL OVERVIEW 108
  3. PRODUCTS/SERVICES OFFERED 109
  4. ABBOTT LABORATORIES: KEY DEVELOPMENTS 109
  5. SWOT ANALYSIS 109
  6. KEY STRATEGIES 110
2. BIO-RAD LABORATORIES, INC. 111
  1. COMPANY OVERVIEW 111
  2. FINANCIAL OVERVIEW 111
  3. PRODUCTS/SERVICES OFFERED 112
  4. KEY DEVELOPMENTS 112
  5. SWOT ANALYSIS 113
  6. KEY STRATEGIES 113
3. DANAHER CORPORATION 114
  1. COMPANY OVERVIEW 114
  2. FINANCIAL OVERVIEW 114
  3. PRODUCTS/SERVICES OFFERED 115
  4. KEY DEVELOPMENTS 115
  5. SWOT ANALYSIS 115
  6. KEY STRATEGIES 115
4. F. HOFFMANN-LA ROCHE LTD 116
  1. COMPANY OVERVIEW 116
  2. FINANCIAL OVERVIEW 116
  3. PRODUCTS/SERVICES OFFERED 117
  4. KEY DEVELOPMENTS 117
  5. SWOT ANALYSIS 117
  6. KEY STRATEGIES 118
5. SIEMENS HEALTHINEERS 119
  1. COMPANY OVERVIEW 119
  2. FINANCIAL OVERVIEW 119
  3. PRODUCTS/SERVICES OFFERED 120
  4. KEY DEVELOPMENTS 120
  5. SWOT ANALYSIS 120
  6. KEY STRATEGIES 121
6. EKF DIAGNOSTICS 122
  1. COMPANY OVERVIEW 122
  2. FINANCIAL OVERVIEW 122
  3. PRODUCTS/SERVICES OFFERED 123
  4. KEY DEVELOPMENTS 123
  5. SWOT ANALYSIS 123
  6. KEY STRATEGIES 124
1. ARKRAY, INC. 125
  1. COMPANY OVERVIEW 125
  2. ARKRAY, INC.: FINANCIAL OVERVIEW 125
  3. PRODUCTS/SERVICES OFFERED 125
  4. KEY DEVELOPMENTS 125
  5. SWOT ANALYSIS 126
  6. KEY STRATEGIES 126
2. TRINITY BIOTECH PLC. 127
  1. COMPANY OVERVIEW 127
  2. FINANCIAL OVERVIEW 127
  3. PRODUCTS/SERVICES OFFERED 128
  4. KEY DEVELOPMENTS 128
  5. SWOT ANALYSIS 128
  6. KEY STRATEGIES 128
3. PTS DIAGNOSTICS 129
  1. COMPANY OVERVIEW 129
  2. FINANCIAL OVERVIEW 129
  3. PRODUCTS/SERVICES OFFERED 129
  4. KEY DEVELOPMENTS 129
  5. SWOT ANALYSIS 130
  6. KEY STRATEGIES 130
4. DIASYS DIAGNOSTIC SYSTEMS GMBH 131
  1. COMPANY OVERVIEW 131
  2. FINANCIAL OVERVIEW 131
  3. PRODUCTS/SERVICES OFFERED 131
  4. KEY DEVELOPMENTS 131
  5. SWOT ANALYSIS 132
  6. KEY STRATEGIES 132
APPENDIX
1. REFERENCES 133
2. RELATED REPORTS 133
List of Tables and Figures
1. 13 List of Tables
2. TABLE 1 LIST OF ASSUMPTIONS 20
3. TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 24
4. TABLE 3 GLOBAL HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 39
5. TABLE 4 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 40
6. TABLE 5 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 40
7. TABLE 6 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 41
8. TABLE 7 GLOBAL HBA1C TESTING MARKET FOR BENCH-TOP DEVICE, BY REGION, 2020–2027 (USD MILLION) 41
9. TABLE 8 GLOBAL HBA1C TESTING MARKET FOR HANDHELD DEVICE, BY REGION, 2020–2027 (USD MILLION) 42
10. TABLE 9 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 44
11. TABLE 10 GLOBAL HBA1C TESTING MARKET FOR ION-EXCHANGE HPLC, BY REGION, 2020–2027 (USD MILLION) 45
12. TABLE 11 GLOBAL HBA1C TESTING MARKET FOR ENZYMATIC ASSAY, BY REGION, 2020–2027 (USD MILLION) 45
13. TABLE 12 GLOBAL HBA1C TESTING MARKET FOR TURBIDIMETRIC INHIBITION IMMUNOASSAY (TINIA), BY REGION, 2020–2027 (USD MILLION) 46
14. TABLE 13 GLOBAL HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 48
15. TABLE 14 GLOBAL HBA1C TESTING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION) 48
16. TABLE 15 GLOBAL HBA1C TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 49
17. TABLE 16 GLOBAL HBA1C TESTING MARKET, BY REGION, 2020–2027 (USD MILLION) 51
18. TABLE 17 AMERICAS: HBA1C TESTING MARKET, BY REGION, 2020–2027 (USD MILLION) 53
19. TABLE 18 AMERICAS: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 53
20. TABLE 19 AMERICAS: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 53
21. TABLE 20 AMERICAS: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 54
22. TABLE 21 AMERICAS: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 54
23. TABLE 22 NORTH AMERICA: HBA1C TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 55
24. TABLE 23 NORTH AMERICA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 56
25. TABLE 24 NORTH AMERICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 56
26. TABLE 25 NORTH AMERICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 57
27. TABLE 26 NORTH AMERICA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 57
28. TABLE 27 US: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 58
29. TABLE 28 US: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 58
30. TABLE 29 US: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 59
31. TABLE 30 US: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 59
32. TABLE 31 CANADA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 60
33. TABLE 32 CANADA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 60
34. TABLE 33 CANADA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 61
35. TABLE 34 CANADA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 61
36. TABLE 35 LATIN AMERICA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 62
37. TABLE 36 LATIN AMERICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 62
38. TABLE 37 LATIN AMERICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 63
39. TABLE 38 LATIN AMERICA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 63
40. TABLE 39 EUROPE: HBA1C TESTING MARKET, BY REGION, 2020–2027 (USD MILLION) 64
41. TABLE 40 EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 65
42. TABLE 41 EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 65
43. TABLE 42 EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 66
44. TABLE 43 EUROPE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 66
45. TABLE 44 WESTERN EUROPE: HBA1C TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 67
46. TABLE 45 WESTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 68
47. TABLE 46 WESTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 68
48. TABLE 47 WESTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 69
49. TABLE 48 WESTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 69
50. TABLE 49 UK: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 70
51. TABLE 50 UK: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 70
52. TABLE 51 UK: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 71
53. TABLE 52 UK: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 71
54. TABLE 53 GERMANY: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 72
55. TABLE 54 GERMANY: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 72
56. TABLE 55 GERMANY: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 73
57. TABLE 56 GERMANY: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 73
58. TABLE 57 FRANCE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 74
59. TABLE 58 FRANCE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 74
60. TABLE 59 FRANCE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 75
61. TABLE 60 FRANCE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 75
62. TABLE 61 ITALY: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 76
63. TABLE 62 ITALY: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 76
64. TABLE 63 ITALY: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 77
65. TABLE 64 ITALY: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 77
66. TABLE 65 SPAIN: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 78
67. TABLE 66 SPAIN: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 78
68. TABLE 67 SPAIN: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 79
69. TABLE 68 SPAIN: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 79
70. TABLE 69 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 80
71. TABLE 70 REST OF WESTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 80
72. TABLE 71 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 81
73. TABLE 72 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 81
74. TABLE 73 EASTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 82
75. TABLE 74 EASTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 82
76. TABLE 75 EASTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 83
77. TABLE 76 EASTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 83
78. TABLE 77 ASIA-PACIFIC: HBA1C TESTING MARKET, BY COUNTRY,2020–2027 (USD MILLION) 84
79. TABLE 78 ASIA-PACIFIC: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 85
80. TABLE 79 ASIA-PACIFIC: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 85
81. TABLE 80 ASIA-PACIFIC: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 86
82. TABLE 81 ASIA-PACIFIC: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 86
83. TABLE 82 CHINA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 87
84. TABLE 83 CHINA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 87
85. TABLE 84 CHINA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 88
86. TABLE 85 CHINA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 88
87. TABLE 86 INDIA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 89
88. TABLE 87 INDIA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 89
89. TABLE 88 INDIA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 90
90. TABLE 89 INDIA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 90
91. TABLE 90 JAPAN: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 91
92. TABLE 91 JAPAN: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 91
93. TABLE 92 JAPAN: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 92
94. TABLE 93 JAPAN: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 92
95. TABLE 94 SOUTH KOREA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93
96. TABLE 95 SOUTH KOREA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 93
97. TABLE 96 SOUTH KOREA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 94
98. TABLE 97 SOUTH KOREA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 94
99. TABLE 98 AUSTRALIA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 95
100. TABLE 99 AUSTRALIA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 95
101. TABLE 100 AUSTRALIA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 96
102. TABLE 101 AUSTRALIA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 96
103. TABLE 102 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 97
104. TABLE 103 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 97
105. TABLE 104 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 98
106. TABLE 105 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 98
107. TABLE 106 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY REGION,2020–2027 (USD MILLION) 99
108. TABLE 107 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 100
109. TABLE 108 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 100
110. TABLE 109 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 101
111. TABLE 110 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 101
112. TABLE 111 MIDDLE EAST: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102
113. TABLE 112 MIDDLE EAST: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 102
114. TABLE 113 MIDDLE EAST: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 103
115. TABLE 114 MIDDLE EAST: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 103
116. TABLE 115 AFRICA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 104
117. TABLE 116 AFRICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 104
118. TABLE 117 AFRICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 105
119. TABLE 118 AFRICA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 105
120. TABLE 119 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED 109
121. TABLE 120 ABBOTT LABORATORIES: KEY DEVELOPMENTS 109
122. TABLE 121 BIO-RAD LABORATORIES INC.: PRODUCTS/SERVICES OFFERED 112
123. TABLE 122 BIO-RAD LABORATORIES, INC.: KEY DEVELOPMENTS 112
124. TABLE 123 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 115
125. TABLE 124 DANAHER CORPORATION: KEY DEVELOPMENTS 115
126. TABLE 125 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED 117
127. TABLE 126 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS 117
128. TABLE 127 SIEMENS HEALTHINEERS: PRODUCTS/SERVICES OFFERED 120
129. TABLE 128 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS 120
130. TABLE 129 EKF DIAGNOSTICS PRODUCTS/SERVICES OFFERED 123
131. TABLE 130 EKF DIAGNOSTICS KEY DEVELOPMENTS 123
132. TABLE 131 ARKRAY, INC.: PRODUCTS/SERVICES OFFERED 125
133. TABLE 132 ARKRAY, INC.: KEY DEVELOPMENTS 125
134. TABLE 133 TRINITY BIOTECH PLC.: PRODUCTS/SERVICES OFFERED 128
135. TABLE 134 PTS DIAGNOSTICS: PRODUCTS/SERVICES OFFERED 129
136. TABLE 135 DIASYS DIAGNOSTIC SYSTEMS GMBH: PRODUCTS/SERVICES OFFERED 131 14 List of Figures
137. FIGURE 1 MARKET SYNOPSIS 14
138. FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS (2020) 15
139. FIGURE 3 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY PRODUCT 16
140. FIGURE 4 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY TECHNOLOGY 17
141. FIGURE 5 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY END USER 18
142. FIGURE 6 GLOBAL HBA1C TESTING MARKET: STRUCTURE 20
143. FIGURE 7 BOTTOM-UP AND TOP-DOWN APPROACHES 26
144. FIGURE 8 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL HBA1C TESTING MARKET 29
145. FIGURE 9 DRIVERS IMPACT ANALYSIS 31
146. FIGURE 10 RESTRAINT IMPACT ANALYSIS 32
147. FIGURE 11 PORTER’S FIVE FORCES ANALYSIS: GLOBAL HBA1C TESTING MARKET 34
148. FIGURE 12 VALUE CHAIN ANALYSIS OF THE GLOBAL HBA1C TESTING MARKET 36
149. FIGURE 13 GLOBAL HBA1C TESTING MARKET SHARE, BY PRODUCT, 2020 (%) 38
150. FIGURE 14 GLOBAL HBA1C TESTING MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION) 38
151. FIGURE 15 GLOBAL HBA1C TESTING MARKET SHARE, BY TECHNOLOGY, 2020 (%) 43
152. FIGURE 16 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY, 2020 & 2027 (USD MILLION) 43
153. FIGURE 17 GLOBAL HBA1C TESTING MARKET SHARE, BY END USER, 2020 (%) 47
154. FIGURE 18 GLOBAL HBA1C TESTING MARKET, BY END USER, 2020 & 2027 (USD MILLION) 47
155. FIGURE 19 GLOBAL HBA1C TESTING MARKET SHARE, BY REGION, 2020 (%) 50
156. FIGURE 20 GLOBAL HBA1C TESTING MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 50
157. FIGURE 21 AMERICAS: HBA1C TESTING MARKET SHARE, BY REGION, 2020 (%) 52
158. FIGURE 22 NORTH AMERICA: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2020 (%) 55
159. FIGURE 23 EUROPE: HBA1C TESTING MARKET SHARE, BY REGION, 2020 (%) 64
160. FIGURE 24 WESTERN EUROPE: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2020 (%) 67
161. FIGURE 25 ASIA-PACIFIC: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2020 (%) 84
162. FIGURE 26 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET SHARE, BY REGION, 2020 (%) 99
163. FIGURE 27 GLOBAL HBA1C TESTING MARKET, MAJOR PLAYER MARKET SHARE ANALYSIS 2020 (%) 106
164. FIGURE 28 INDIA HBA1C TESTING MARKET, MAJOR PLAYER MARKET SHARE ANALYSIS 2020 (%) 107
165. FIGURE 29 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT 108
166. FIGURE 30 ABBOTT LABORATORIES: SWOT ANALYSIS 109
167. FIGURE 31 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 111
168. FIGURE 32 BIO-RAD LABORATORIES INC: SWOT ANALYSIS 113
169. FIGURE 33 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 114
170. FIGURE 34 DANAHER CORPORATION: SWOT ANALYSIS 115
171. FIGURE 35 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 116
172. FIGURE 36 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 117
173. FIGURE 37 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT 119
174. FIGURE 38 SIEMENS HEALTHINEERS: SWOT ANALYSIS 120
175. FIGURE 39 EKF DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT 122
176. FIGURE 40 EKF DIAGNOSTICS: SWOT ANALYSIS 123
177. FIGURE 41 ARKRAY, INC.: SWOT ANALYSIS 126
178. FIGURE 42 TRINITY BIOTECH PLC.: FINANCIAL OVERVIEW SNAPSHOT 127
179. FIGURE 43 TRINITY BIOTECH PLC.: SWOT ANALYSIS 128
180. FIGURE 44 PTS DIAGNOSTICS: SWOT ANALYSIS 130
181. FIGURE 45 DIASYS DIAGNOSTIC SYSTEMS GMBH: SWOT ANALYSIS 132'

HbA1c Testing Market Segmentation

Market Segmentation Overview

Detailed segmentation data will be available in the full report
Comprehensive analysis by multiple parameters
Regional and country-level breakdowns
Market size forecasts by segment

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027